Click Here for 5% Off Your First Aladdin Purchase!

BrP-LPA , CAS No.944313-05-7, Antagonist of LPA 1 receptor;Antagonist of LPA 2 receptor

  • Moligand™
Item Number
B608229
Grouped product items
SKUSizeAvailabilityPrice Qty
B608229-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$650.90
B608229-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,160.90

Basic Description

Synonymsα-bromomethylene phosphonate
Specifications & PurityMoligand™
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of LPA 1 receptor;Antagonist of LPA 2 receptor

Associated Targets

ENPP2 Tchem Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TRPV1 Tclin Transient receptor potential cation channel subfamily V member 1 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

LPAR1 Tchem Lysophosphatidic acid receptor 1 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

LPAR2 Tchem Lysophosphatidic acid receptor 2 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name [(3S)-1-bromo-4-hexadecanoyloxy-3-hydroxybutyl]phosphonic acid
INCHI InChI=1S/C20H40BrO6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-20(23)27-17-18(22)16-19(21)28(24,25)26/h18-19,22H,2-17H2,1H3,(H2,24,25,26)/t18-,19?/m0/s1
InChi Key HLVKVWDSLLFMSX-OYKVQYDMSA-N
Canonical SMILES CCCCCCCCCCCCCCCC(=O)OC[C@H](CC(P(=O)(O)O)Br)O
Isomeric SMILES CCCCCCCCCCCCCCCC(=O)OC[C@H](CC(P(=O)(O)O)Br)O
PubChem CID 16725999

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Zhang H, Xu X, Gajewiak J, Tsukahara R, Fujiwara Y, Liu J, Fells JI, Perygin D, Parrill AL, Tigyi G et al..  (2009)  Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo..  Cancer Res,  69  (13): (5441-9).  [PMID:19509223]

Solution Calculators